J&J Cypher Panel Date Presages Year-End Approval; Achieve Cleared In EU

Clinical data to be reviewed by FDA's Circulatory System Devices Panel Oct. 22 will include nine-month SIRIUS trial safety results on Johnson & Johnson's sirolimus-eluting Cypher stent